Mantle Cell Lymphoma Life Expectancy Depends On Various Factors

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of non-Hodgkin's lymphoma, and it generally does not have a good prognosis. It is a very rare disease, affecting no more than about 4,000 people (generally men and generally older than 60) in the US every year. This is the equivalent of about 5% of all non-Hodgkin's lymphoma diagnoses made annually.

Mantle cell lymphoma is poorly understood by the medical community, largely because it was only recognized as a legitimately unique B-cell NHL subtype twenty years ago. In that time, a wide variety of treatments—including chemotherapy, radiotherapy, stem cell transplantations, and immunotherapy—have been applied to patients with mantle cell lymphoma, with varying results, none of them especially convincing or leading to much enthusiasm in the research community.

Life Expectancy

The life expectancy for any patient receiving a diagnosis of mantle cell lymphoma will vary widely, depending on various factors ranging from age and health status, to stage of the disease at diagnosis and whether the patient has so-called B symptoms or not. The problem is that in many instances, and following virtually all modes of treatment, the disease is extremely prone to returning; relapse in is very common, and when relapse occurs, the relapsed disease has all too commonly become chemo-resistant as well.

Thus, while it is impossible to say how long any one individual patient will survive following a diagnosis of mantle cell lmyphoma, currently the life expectancy is cited as being in the range of four to five years following diagosis, according to researchers at the John Theurer Cancer Center in Hackensack, New Jersey.

Sources

Related Reading

Photo: Pexels

More Articles

More Articles

The term 'metastatic lymphoma' does not refer to a diagnosis. Unlike many of the subtypes of lymphoma we have...

It is nearly impossible to talk about a survival rate for...

Lymphosarcoma is a malignant tumor (or tumors) derived from lymphoid tissue (lymph nodes, tonsils, thymus, spleen, etc.). It is an illness that...

Diffuse Large B-Cell Lymphoma (DLBCL) is an aggressive Non-Hodgkin’s Lymphoma (NHL) that occurs in B-cells....

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A lymphoma diagnosis is not difficult to determine once a patient and doctor begin to look for signs of cancer...

The lymphatic system, or lymph system, defends the body from foreign invasion by disease causing agents such as viruses, bacteria, or fungi. The...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphoma is a general term for cancer in the lymph system. The lymph system is made up of many cells and organs, including the lymph nodes, thymus...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...